PRACTITIONER APPLICATION: Organizational Design Consistency: The PennCARE and Henry Ford Health System Experiences

2002 ◽  
Vol 47 (5) ◽  
pp. 318-319
Author(s):  
Susan L. Browning
Keyword(s):  
Health System ◽  
Organizational Design ◽  
Henry Ford ◽  
Design Consistency

The Henry Ford Health System

Cancer ◽  
1998 ◽  
Vol 82 (S10) ◽  
pp. 2043-2046 ◽  
Author(s):  
Raymond Y. Demers ◽  
Robert A. Chapman ◽  
Michael H. Flasch ◽  
Cheryl Martin ◽  
Bruce D. McCarthy ◽  
...  
Keyword(s):  
Health System ◽  
Henry Ford

The Henry Ford Health System No Harm Campaign: A Comprehensive Model to Reduce Harm and Save Lives

2012 ◽  
Vol 38 (7) ◽  
pp. 318-AP1 ◽  
Author(s):  
William A. Conway ◽  
Susan Hawkins ◽  
Jack Jordan ◽  
Mary J. Voutt-Goos
Keyword(s):  
Health System ◽  
Comprehensive Model ◽  
Henry Ford

scholarly journals ANALISA DRUG RELATED PROBLEMS (DRPs) PADA PASIEN CHRONIC KIDNEY DISEASE (CKD) DI INSTALASI RAWAT INAP KLINIK SARI MEDIKA KABUPATEN SEMARANG

2021 ◽  
Vol 4 (1) ◽  
pp. 1-5
Author(s):  
Poppy Diah Palupi ◽  
Veronika Jayaningsih
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Health System ◽  
Clinical Pathway ◽  
Drug Related Problems ◽  
Purposive Sampling ◽  
Henry Ford

Drug Related Problems (DRPs) merupakan kejadian yang tidak diinginkan yang dialami oleh pasien dan berkaitan dengan pengobatan sehingga berpotensi mengganggu keberhasilan terapi. Penelitian ini bertujuan untuk mengetahui dan menganalisa DRPs yang terjadi pada pasien Chronic Kidney Disease (CKD) di instalasi rawat inap klinik Sari Medika kabupaten Semarang. Penelitian ini merupakan penelitian deskriptif dengan pengumpulan data secara retrospektif pada pasien CKD yang diperoleh dari data rekam medis. Pengambilan sampel menggunakan teknik purposive sampling. Acuan yang digunakan pada penelitian ini adalah Pharmacotherapy Handbook 9th edition 2015, Kidney Disease Improving Global Outcomes (KDIGO), The Renal Drug Handbook 3rd edition 2009, Panduan Praktik Klinis & Clinical Pathway Penyakit Jantung, Pembuluh Darah 2016, dan Henry Ford Health System 6th edition 2011. Hasil penelitian yang dilakukan pada 84 pasien CKD menunjukkan bahwa terdapat DRPs pada 66 pasien dengan kategori yaitu indikasi tanpa terapi (30.86%), terapi tanpa indikasi (6.17%), dosis sub terapi (1.23%), dosis obat berlebih (13.58%), pemilihan obat tidak tepat (45.68%), dan penderita gagal menerima obat (2.47%).

scholarly journals Henry ford health system global health initiative’s “Research Training to Research Project Model”

2016 ◽  
Vol 82 (3) ◽  
pp. 348
Author(s):  
D. Dankerlui ◽  
D. Parke ◽  
T. Prentiss ◽  
J. Zervos ◽  
A. Plum ◽  
...  
Keyword(s):  
Global Health ◽  
Health System ◽  
Research Training ◽  
Research Project ◽  
Henry Ford ◽  
Project Model

scholarly journals The Current State of Opioid Prescribing and Drug Enforcement Agency (DEA) Action Against Physicians: An Analysis of DEA Database 2004-2017

2020 ◽  
Vol 3;23 (6;3) ◽  
pp. E297-E304
Author(s):  
David Daewhan Kim
Keyword(s):  
Risk Factors ◽  
Health System ◽  
Private Practice ◽  
Board Certification ◽  
Pain Medicine ◽  
Medical Purpose ◽  
Drug Enforcement ◽  
Henry Ford ◽  
Drug Enforcement Agency ◽  
Gender Type

Background: Prescribing opioids has become a challenge. The US Drug Enforcement Agency (DEA) and Centers for Disease Control and Prevention (CDC) have become more involved, culminating in the March 2016 release of the CDC’s “Guidelines for Prescribing Opioids for Chronic Pain.” Objectives: Given the new guidelines, we wanted to see if there have been any changes in the numbers, demographics, physician risk factors, charges, and sanctions involving the DEA against physicians who prescribe opioids, when compared to a previous DEA database review from 1998 to 2006. Study Design: This study involved an analysis of the DEA database from 2004 to 2017. Setting: The review was conducted at the Henry Ford Health System Division of Pain Medicine. Method: After institutional review board approval at Henry Ford Health System, an analysis of the DEA database of criminal prosecutions of physician registrants from 2004-2017 was performed. The database was reviewed for demographic information such as age, gender, type of degree (doctor of medicine [MD] or doctor of osteopathic medicine [DO]), years of practice, state, charges, and outcome of prosecution (probation, sentencing, and length of sentencing). An internet-based search was performed on each registrant to obtain demographic data on specialty, years of practice, type of medical school (US vs foreign), board certification, and type of employment (private vs employed). Results: Between 2004 and 2017, Pain Medicine (PM) had the highest percentage of in-specialty action at 0.11% (n = 5). There was an average of 18 prosecutions per year vs 14 in the previous review. Demographic risk factors for prosecution demonstrated the significance of the type of degree (MD vs. DO), gender, type of employment (private vs. employed), and board certification status for rates of prosecution. Having a DO degree and being male were associated with significantly higher risk as well as being in private practice and not having board certification (P < .001). In terms of type of criminal charges as a percent of cases, possession with intent to distribute (n = 90) was most prevalent, representing 52.3% of charges, with new charges being prescribing without medical purpose outside the usual course of practice (n = 71) representing 41.3% of charges. Comparison of US graduates (MD/DO) vs. foreign graduates showed higher rates of DEA action for foreign graduates but this was of borderline significance (P = .072). Limitations: State-by-state comparisons could not be made. Specialty type was sometimes selfreported, and information on all opioid prosecutions could not be obtained. The previous study by Goldenbaum et al included data beyond DEA prosecution, so direct comparisons may be limited. Conclusion: The overall risk of DEA action as a percentage of total physicians is small but not insignificant. The overall rates of DEA prosecution have increased. New risk factors include type of degree (DO vs. MD) and being in private practice with a subtle trend toward foreign graduates at higher risk. With the trend toward less prescribing by previously high-risk specialties such as Family Medicine, there has been an increase in the relative risk of DEA action for specialties treating patients with pain such as PM, Physical Medicine and Rehabilitation, neurology, and neurosurgery bearing the brunt of prosecutions. New, more subtle charges have been added involving interpretation of the medical purpose of opioids and standard of care for their use. Key words: Certification, CDC, criminal, DEA, opioid, prescribing, prosecution, sanctions

Sign in / Sign up

Export Citation Format

Share Document